VIB VZW (20250011793). Oligonucleotides for Modulating Synaptogyrin-3 Expression
Oligonucleotides for Modulating Synaptogyrin-3 Expression
Organization Name
Inventor(s)
Patrik Verstreken of Blanden BE
Oligonucleotides for Modulating Synaptogyrin-3 Expression
This abstract first appeared for US patent application 20250011793 titled 'Oligonucleotides for Modulating Synaptogyrin-3 Expression
Original Abstract Submitted
the invention relates to identification of regions within the synaptogyrin-3 rna sequence that are targetable by oligonucleotide inhibitors. in particular, these synaptogyrin-3 inhibitors are provided for use as a medicament in general, and for treating or inhibiting progression of tauopathies or symptoms of tauopathies.
(Ad) Transform your business with AI in minutes, not months
✓
Custom AI strategy tailored to your specific industry needs
✓
Step-by-step implementation with measurable ROI
✓
5-minute setup that requires zero technical skills
Trusted by 1,000+ companies worldwide
